Brief: IMAC Holdings Completes First Infusion Of Stem Cells In Clinical Study For The Treatment Of Bradykinesia Due To Parkinson’S Disease
30/12/2020 14:15
Dec 30 (Reuters) - IMAC Holdings Inc IMAC.O :
* IMAC HOLDINGS COMPLETES FIRST INFUSION OF STEM CELLS IN
CLINICAL
STUDY FOR THE TREATMENT OF BRADYKINESIA DUE TO PARKINSON’S
DISEASE
Source text for Eikon: ID:nGNX6DY9S1
Further company coverage: IMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imac Holdings
See all newsBrief: Nasdaq To Suspend Imac Holdings Stock Trading On March 26, 2025
Imac Holdings Inc Reports Results For The Quarter Ended September 30: Earnings Summary
Brief: Imac Holdings Inc - Regains Compliance With Nasdaq Audit Committee Rule
Imac Holdings Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Brief: IMAC Holdings Enters Agreement To Issue 4,676 Shares Of Series G Preferred Stock